Company / Capital Returned to Shareholders per Share
ResMed Capital Returned to Shareholders per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Returned to Shareholders per Share
$4.16
FY2025
5-year range
$1.56 / $4.16
FY2021-FY2025
Trend
+41.5%
vs FY2024
Sector context
#34 of 103
Health Care
What the data says
At $4.16, ResMed's capital returned to shareholders per share ranks #34 of 103 in the Health Care sector. Capital Returned to Shareholders per Share has increased for 4 consecutive years, from $1.56 in FY2021 to $4.16 in FY2025.
Based on SEC 10-K filings.
4.16 in FY2025 with a 5-year CAGR of +21.6%.
Improved from $1.76 to $4.16 over the past 2 years.
Health Care sector context is included.
Capital Returned to Shareholders per Share over time
Growth rates
- 3-Year CAGR
- +35.2%
- 5-Year CAGR
- +21.6%
- 10-Year CAGR
- -
Sector benchmark
-18.0% below sector average
Key checks
Key Insights
- ResMed's capital returned to shareholders per share has grown for 4 consecutive years.
- In FY2025, capital returned to shareholders per share increased 41.5% year-over-year.
- Ranks #34 out of 103 companies in the Health Care sector.
- Lowest capital returned to shareholders per share in the period was in FY2017.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Altman Z-Score 3.25 (safe zone, above 2.9 threshold)
- Strong profit margin: 27.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital Returned to Shareholders per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.16 | +41.5% |
| FY2024 | $2.94 | +66.6% |
| FY2023 | $1.76 | +4.7% |
| FY2022 | $1.68 | +7.7% |
| FY2021 | $1.56 | -0.1% |
| FY2020 | $1.57 | -4.7% |
| FY2019 | $1.64 | -7.7% |
| FY2018 | $1.78 | +34.5% |
| FY2017 | $1.32 | -31.1% |
| FY2016 | $1.92 | -15.0% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026